Universal-Beteiligungs- und Servicegesellschaft
NTLA icon

Universal-Beteiligungs- und Servicegesellschaft’s Intellia Therapeutics NTLA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.23M Buy
190,673
+3,892
+2% +$54.5K ﹤0.01% 1108
2026
Q1 		$2.39M Buy
186,781
+88,184
+89% +$1.12M ﹤0.01% 1182
2025
Q4 		$893K Sell
98,597
-14,841
-13% -$204K ﹤0.01% 1528
2025
Q3 		$1.96M Buy
113,438
+48,438
+75% +$597K ﹤0.01% 1305
2025
Q2 		$610K Hold
65,000
– – ﹤0.01% 1633
2025
Q1 		$462K Buy
+65,000
New +$657K ﹤0.01% 1669

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's NTLA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Intellia Therapeutics (NTLA) stake by 2.1% in Q2 2026, buying an estimated $54.5K and bringing the position to 190,673 shares worth $3.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in NTLA in Q1 2025 and has held it in 6 quarters since. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 190,673 shares of Intellia Therapeutics worth $3.23M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 3,892 Intellia Therapeutics shares in Q2 2026, an estimated $54.5K.
  • Intellia Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1108 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Intellia Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.